Outset Medical (OM) Common Equity (2018 - 2026)

Outset Medical (OM) has 9 years of Common Equity data on file, last reported at $111.7 million in Q1 2026.

• Quarterly Common Equity fell 34.25% year-over-year to $111.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $111.7 million (down 34.25% YoY) and the FY2025 annual result came in at $127.0 million, up 373.37% from the prior year.
• Common Equity retreated to $111.7 million in Q1 2026 per OM's latest filing, from $127.0 million in the prior quarter.
• Across five years, Common Equity topped out at $345.5 million in Q1 2022 and bottomed at $26.8 million in Q4 2024.
• The 5-year median for Common Equity is $152.1 million (2023), against an average of $164.5 million.
• The widest annual swing landed in 2024, when Common Equity plunged 78.18%; it then surged 373.37% in 2025.
• Tracing OM's Common Equity over 5 years: stood at $246.0 million in 2022, then plunged by 50.04% to $122.9 million in 2023, then sank by 78.18% to $26.8 million in 2024, then surged by 373.37% to $127.0 million in 2025, then declined by 12.02% to $111.7 million in 2026.
• Per Business Quant, the three latest OM Common Equity figures stand at $111.7 million (Q1 2026), $127.0 million (Q4 2025), and $142.4 million (Q3 2025).

Peer Comparison